CINECA IRIS Institutional Research Information System

BERNENGO, Maria Grazia
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 15.460
EU - Europa 10.232
AS - Asia 10.152
SA - Sud America 1.415
AF - Africa 227
OC - Oceania 98
Continente sconosciuto - Info sul continente non disponibili 23
Totale 37.607
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 15.037
SG - Singapore 3.564
CN - Cina 3.551
IT - Italia 2.628
FR - Francia 1.244
BR - Brasile 1.097
IE - Irlanda 1.082
DE - Germania 935
VN - Vietnam 891
FI - Finlandia 798
KR - Corea 719
SE - Svezia 717
UA - Ucraina 695
AT - Austria 481
GB - Regno Unito 475
PL - Polonia 361
IN - India 339
CA - Canada 273
HK - Hong Kong 234
JP - Giappone 226
ES - Italia 137
DK - Danimarca 119
AR - Argentina 115
NL - Olanda 110
MX - Messico 96
AU - Australia 89
TR - Turchia 87
IQ - Iraq 80
BD - Bangladesh 76
RU - Federazione Russa 74
ID - Indonesia 70
GR - Grecia 61
BE - Belgio 59
CH - Svizzera 57
SN - Senegal 54
CO - Colombia 53
ZA - Sudafrica 50
EC - Ecuador 39
CL - Cile 33
PK - Pakistan 32
PT - Portogallo 31
TW - Taiwan 30
EG - Egitto 29
RO - Romania 29
MA - Marocco 25
IR - Iran 24
VE - Venezuela 24
AE - Emirati Arabi Uniti 23
TH - Thailandia 23
NO - Norvegia 22
EU - Europa 20
IL - Israele 20
UZ - Uzbekistan 19
KE - Kenya 17
PY - Paraguay 17
CZ - Repubblica Ceca 16
PE - Perù 16
PH - Filippine 16
DZ - Algeria 15
JO - Giordania 15
SA - Arabia Saudita 15
HR - Croazia 14
HU - Ungheria 14
UY - Uruguay 13
LB - Libano 11
MY - Malesia 11
NP - Nepal 11
AL - Albania 9
BG - Bulgaria 9
LV - Lettonia 9
OM - Oman 9
RS - Serbia 9
CR - Costa Rica 8
MU - Mauritius 8
JM - Giamaica 7
NZ - Nuova Zelanda 7
SK - Slovacchia (Repubblica Slovacca) 7
BY - Bielorussia 6
DO - Repubblica Dominicana 6
HN - Honduras 6
MO - Macao, regione amministrativa speciale della Cina 6
PA - Panama 6
SV - El Salvador 6
TN - Tunisia 6
BA - Bosnia-Erzegovina 5
KW - Kuwait 5
KZ - Kazakistan 5
LT - Lituania 5
PS - Palestinian Territory 5
QA - Qatar 5
SI - Slovenia 5
AZ - Azerbaigian 4
BB - Barbados 4
BO - Bolivia 4
ET - Etiopia 4
GT - Guatemala 4
GY - Guiana 4
LK - Sri Lanka 4
BN - Brunei Darussalam 3
CG - Congo 3
Totale 37.551
Salva come PNG Salva come JPEG
Città #
Beijing 2.377
Singapore 1.865
Chandler 1.510
Dublin 1.074
Santa Clara 898
San Jose 866
Ashburn 842
Villeurbanne 571
Houston 528
Jacksonville 521
Princeton 455
Vienna 452
Medford 431
Ann Arbor 421
Dallas 399
Fairfield 349
The Dalles 348
Dearborn 326
Warsaw 319
Columbus 313
Wilmington 309
Torino 292
Lauterbourg 273
Los Angeles 269
Ho Chi Minh City 233
Milan 227
Woodbridge 218
Redwood City 188
Hanoi 187
Buffalo 184
Nyköping 180
Hong Kong 174
Seattle 160
Helsinki 149
Cambridge 147
New York 120
Pisa 116
Tokyo 113
Boardman 112
Seoul 112
São Paulo 111
Toronto 108
Hefei 104
Rome 103
Boston 101
Guangzhou 96
Pune 93
Dong Ket 86
Fremont 78
Munich 76
Shanghai 76
Verona 68
Washington 62
Turin 57
Nanjing 55
Council Bluffs 49
Turku 49
Falls Church 47
Brussels 45
Lachine 44
Frankfurt am Main 43
Norwalk 43
Da Nang 39
Jakarta 38
Chicago 35
Bengaluru 34
Baghdad 33
Chengdu 32
Nuremberg 32
Orem 32
Napoli 31
Phoenix 31
Athens 30
Florence 29
Mexico City 29
Haiphong 28
Jinan 28
Kunming 28
Des Moines 27
Rio de Janeiro 27
Atlanta 25
Hangzhou 25
Paris 25
London 24
Madrid 24
Zhengzhou 24
Belo Horizonte 23
Biên Hòa 22
Brooklyn 22
Stockholm 22
Buenos Aires 21
Chennai 21
Johannesburg 21
Leiden 21
Montreal 21
San Diego 21
San Francisco 21
Porto Alegre 20
Santiago 20
Sydney 20
Totale 21.228
Salva come PNG Salva come JPEG
Nome #
Prospective International Multicenter Phase II Trial of Intravenous Pegylated Liposomal Doxorubicin Monochemotherapy in Patients With Stage IIB, IVA, or IVB Advanced Mycosis Fungoides: Final Results From EORTC 21012. 866
Th1, Th2, Th17 and Regulatory T Cell Pattern in Psoriatic Patients: Modulation of Cytokines and Gene Targets Induced by Etanercept Treatment and Correlation with Clinical Response. 710
Functional and phenotypical alterations of polymorphonuclear cells in Sézary syndrome patients [*MT. Fierro and AMC Cuffini contributed equally to this work] 458
Melanoma of unknown primary site: a 33-year experience at the Turin Melanoma Centre. 440
Malattie bollose autoimmuni: casisitica clinica e approccio terapeutico 433
Clinicopathologic spectrum of cutaneous diseases in patients with hematologic malignancies with or without allogeneic bone marrow transplantation: an observational cohort study in 101 patients. 413
Vitiligo is an independent favourable prognostic factor in stage III and IV metastatic melanoma patients: results from a single-institution hospital-based observational cohort study 355
Atopic dermatitis in a phenylketonuric untreated patient 346
Regulatory T cells in skin lesions and blood of patients with bullous pemphigoid 344
Patologie dermatologie e rischio di neoplasia in pazienti portatori di trapianto di rene: revisione della casistica torinese 343
Melanoma of the lower extremities: foot site is an independent risk factor for clinical outcome 305
Circulating CD4+ CD25brightFOXP3+ regulatory T-cells are significantly reduced in bullous pemphigoid patients. 305
Effectiveness of extracorporeal photochemotherapy in the treatment of a case of refractory erosive lichen planus 304
Functional and Phenotypical Impairment of Polymorphonuclear Cells in Atopic Dermatitis: An Additional Cause for the Known Susceptibility to Infections? [*M.T. Fierro and G. Banche contributed equally to this work] 295
Efficacia della fotochemioterapia extracorporea nel trattamento di un caso di lichen erosivo 289
Giornale italiano di Dermatologia e Venereologia 282
Thymopentin down-regulates both activity and expression of iNOS in blood cells of Sézary syndrome patients 277
Metastasi ossee da melanoma: incidenza e impatto sulla sopravvivenza 275
The inclusion complex of 4-hydroxynonenal with a polymeric derivative of Β-cyclodextrin enhances the antitumoralefficacyof the aldehyde in several tumor cell lines and in a three-dimensional human melanoma model 267
Reciprocal modulation of circulating CD4+CD25+bright T cells induced by extracorporeal photochemotherapy in cutaneous T-cell lymphoma and chronic graft-versus-host-disease patients. 261
High-dose immunoglobulines and extracorporeal photochemotherapy in the treatment of febrile ulceronecrotic Mucha-Habermann disease. 259
Effectiveness of electrochemotherapy in treatment of a recurrent squamous cell carcinoma of the scalp. 257
Expression of AP-2a, AP-2g and ESDN in primary melanomas: Correlation with histopathological features and potential prognostic value 251
Alterazioni funzionali e fenotipiche dei polimorfonucleati nella sindrome di sezary 246
Adult-onset cutaneous mastocytosis in monozygotic twins. 238
Italian Euromelanoma Day Screening Campaign (2005-2007) and the planning of melanoma screening strategies. 233
Epstein-Barr virus in cutaneous T-cell lymphomas: evaluation of the viral presence and significance in skin and peripheral blood 223
Alterazioni funzionali e fenotipiche dei polimorfonucleati nei pazienti affetti da dermatite atopica 213
Relevance of multiple basin drainage and primary histologic regression in prognosis of trunk melanoma patients with negative sentinel lymph nodes. 210
Malattia di Castleman multicentrica associata a sarcoma di Kaposi Savoia P, Fierro MT, Quaglino P, Zaccagna A, Bernengo MG 203
BANS: a discussion of the problem. 199
Long-term evolution of an untreated primary cutaneous follicle center lymphoma of the scalp 198
Halo nevi related to treatment with imatinib in a dermatofibrosarcoma protuberans patient 186
A retrospective analysis of the costs and management of genital warts in Italy. 185
microRNA-214 promotes melanoma tumor progression 178
Alemtuzumab for the treatment of Sézary sindrome: clinical and immunological findings in 10 patients. 176
Detection of HIV p24 from antigen presenting monocytes for early diagnosis of HIV-1 infection. 172
Clinico-pathologic features of primary melanoma and sentinel lymph node predictive for non-sentinel lymph node involvement and overall survival in melanoma patients: A single centre observational cohort study. 171
[Cutaneous melanoma at the Turin Melanoma Center. I. Survival and correlation with clinical and histologic prognostic factors in 502 patients in stage I (1975-1985)] 170
[Pemphigus-pemphigoid mixed bullous dermatosis in chronic lymphatic leukemia] 169
Active rosette test in cutaneous lymphoproliferative disorders. 169
[Activity of deoxycytidylate-deaminase in human lymphocytes stimulated with phytohemagglutinin] 169
microRNA-214 contributes to melanoma tumor progression through suppression of TFAP2C 167
Functional properties in Sézary cells with an unusual phenotype. 163
Prognostic differences across sexes in melanoma patients: What has changed from the past? 163
L'elettrochemioterapia nel trattamento del sarcoma di Kaposi: l'esperienza di Roma e Torino 161
[Serum levels of soluble receptors of interleukin-2 in skin pathology] 160
Favourable prognostic role of regression of primary melanoma in AJCC stage I-II patients. 159
microRNA-214 contributes to melanoma tumor progression through suppression of TFAP2C 157
Fotoferesi: applicazioni terapeutiche “off-label” 157
Rischio di recidiva ed intervallo libero da malattia: linee guida di terapia e follow-up. 154
Improved Anti-Tumoral Therapeutic Efficacy of 4-Hydroxynonenal Incorporated in Novel Lipid Nanocapsules in 2D and 3D Models 154
VENTI ANNI DI ESPERIENZA CON LA FOTOFERESI 153
microRNA-214 contributes to melanoma tumor progression through suppression of TFAP2C 153
Changes in T and B lymphocyte subpopulations before, during and after chemotherapy for malignant melanoma. 152
Endothelial and Smooth muscle cell Derived Neuropin-like molecule and AP-2 family protein expression in primary melanoma predicts Disease Free Survival in melanoma patients 151
Peripheral blood involvement in a mycosis fungoides patient with limited skin lesions: phenotypical features and homing molecule pattern 151
A case of acute promyelocytic leukaemia with bullous, haemorrhagic and necrotic skin lesions. 150
Collagenase digestion and mechanical disaggregation as a method to extract and immunophenotype tumour lymphocytes in cutaneous T-cell lymphomas. 150
[Pemphigus induced by monoclonal IgM with anti-IgG antibody activity in a case of Waldenström's 's 's macroglobulinemia] 148
[Effect of methotrexate on DNA synthesis in human lymphocytes stimulated with phytohemagglutinin] 147
Human herpesvirus 7 detection by quantitative real time polymerase chain reaction in primary cutaneous T-cell lymphomas and healthy subjects: lack of a pathogenic role 147
[Cutaneous melanoma at the Turin Melanoma Center. II. Risk of metastasis and free interval in relation to the clinical and histological prognostic factors in 502 patients in stage I (1975-1985)] 145
1975-2011 Overall Survival, Disease Free Survival and Survival after Recurrence across gender in melanoma patients: what has changed? 145
Variable CD7 expression on T cells in the leukemic phase of cutaneous T cell lymphoma (Sézary syndrome). 144
Prognostic factors in primary cutaneous B-cell lymphoma: the Italian Study Group for Cutaneous Lymphomas. 144
Low-dose intermittent alemtuzumab in the treatment of Sézary syndrome: clinical and immunologic findings in 14 patients. 144
Prognostic relevance of baseline and sequential peripheral blood tyrosinase expression in 200 consecutive advanced metastatic melanoma patients. 143
EPILUMINESCENZA DIGITALE NEI MELANOMI SOTTILI: CORRELAZIONI CON I PARAMETRI CLINICO-PATOLOGICI 143
Macrophage-mediated immunostimulation modulates therapeutic efficacy of interleukin-2 based chemoimmunotherapy in advanced metastatic melanoma patients. 142
[Heterogenicity of T-cell cutaneous lymphomas: pleomorphic lymphoma of intermediate phenotype between the thymic and post-thymic stages. Study of 2 cases] 141
Bullous pemphigoid is characterised by a reduction of skin-homing/circulating FOXP3+ Tregs and by a down-regulation of the IL-10 pathway 141
Cholesteryl butyrate solid lipid nanoparticles as a butyric acid pro-drug: effects on cell proliferation, cell-cycle distribution and c-myc expression in human leukemic cells 141
Multivariate analysis of prognostic factors in 58 Sézary syndrome patients 138
Associazione di ciclofosfamide, vincristina e prednisone (COP) nel trattamento dei linfomi cutanei: 20 anni di follow-up. 137
Low-dose intermittent Alemtuzumab in Sézary Syndrome: clinical activity, toxicity profile and immunological findings in 17 patients. 135
Electrochemotherapy with intravenous bleomycin in the treatment of cutaneous and subcutaneous metastases: results of a prospective single centre trial 135
T-cell subsets in melanoma patients evaluated by anti-T-cell monoclonal antibodies. 134
Adhesion molecules in lymphomatoid granulomatosis 133
Multiple pyogenic granuloma of the penis. 132
CD26 (DPP-IV)- A useful marker in Sezary sindrome 132
Melanoma maligno della congiuntiva con infiltrazione sclerale e metastasi mediastiniche: case report 131
Circulating CD4+CD25 bright FOXP3+ T cells are up-regulated by biological therapies and correlate with the clinical response in psoriasis patients. 131
VEGF-165 serum levels and tyrosinase expression in melanoma patients: correlation with the clinical course. 131
Prognostic factors in Sezary sindrome 130
Prevention of recurrences in frequently relapsing herpes labialis with thymopentin. A randomized double-blind placebo-controlled multicenter study. 129
Biological prognostic factors in advanced metastatic melanoma patients treated with chemoimmunotheraphy. 129
CD26 expression on cutaneous infiltrates from patients CD26 expression on cutaneous infiltrates from patients with cutaneous T-cell lymphoma (CTCL) CD26 in cutaneous T-cell lymphoma patients. 128
Clinical and prognostic reports from 270 patients with multiple primary melanomas: a 34-year single-institution study 128
Electrochemotherapy in treatment of skin melanoma metastases 128
Leucosis and skin: acute lymphoid immunoblastic leukaemia. 126
[Lymphomatoid papulosis transforming to Hodgkin's disease] 126
The prognostic value of T-lymphocyte levels in malignant melanoma. A five-year follow-up. 126
Adjuvant therapy of stage IIIb melanoma with interferon alfa-2b: clinical and immunological relevance 125
Le infezioni nella micosi fungoide e nella sindrome di Sézary 125
Attività clinica e modulazione immunologica di bexarotene a basse dosi: presentazione di un caso 125
Clinic-pathologic features of sentinel lymph nodes predictive for non-sentinel lymph node involvement, disease-free survival and overall survival in melanoma patients 125
Improvement of sensitivity in sentinel lymph node procedure in melanoma patients. 124
Phenotypical and functional alterations of polymorphonucleates in sezary syndrome patients 124
PAS expression is related to survival in Sézary syndrome patients 123
Totale 20.203
Salva come PNG Salva come JPEG
Categoria #
all - tutte 111.252
article - articoli 0
book - libri 0
conference - conferenze 39.569
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 150.821
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021449 0 0 0 0 0 0 0 0 0 0 191 258
2021/20222.499 63 92 138 135 150 106 161 123 86 131 484 830
2022/20234.440 621 274 105 351 492 1.110 388 265 445 78 209 102
2023/20241.764 231 293 124 98 119 244 68 67 18 83 126 293
2024/20255.032 68 351 152 434 1.267 227 156 263 634 316 388 776
2025/20269.173 927 480 865 1.227 1.251 568 1.496 431 764 894 270 0
Totale 38.707